Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Cue Biopharma, Inc. (CUE) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $11.81 Metrics
OS: 45.0 M
Market cap: $531 M
Net cash: $53.9 M $1.20 per share
EV: $477 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues1.214.93.23.51.10.00.00.0
            Revenue growth-91.7%373.7%-8.8%202.7%    
Cost of goods sold0.00.00.00.00.00.00.00.0
Gross profit1.214.93.23.51.10.00.00.0
            Gross margin100.0%100.0%100.0%100.0%100.0%   
Selling, general and administrative54.558.748.2     
Research and development   27.528.518.95.71.5
General and administrative   12.711.34.32.00.4
EBITA-52.8-43.6-45.1-36.8-38.7-23.2-7.7-1.9
            EBITA margin-4239.9%-291.9%-1431.1%-1062.9%-3386.7%   
Amortization of intangibles   0.0    
EBIT-52.8-43.6-45.1-36.8-38.7-23.2-7.7-1.9
            EBIT margin-4239.9%-291.9%-1431.1%-1063.2%-3386.7%   
Pre-tax income-53.0-43.7-44.6-36.3-38.2-23.2-7.7-1.9
Income taxes0.00.50.20.40.80.00.00.0
            Tax rate0.0%    0.0%0.0%0.0%
Net income-53.0-44.2-44.8-36.7-39.0-23.2-7.7-1.9
            Net margin-4257.1%-295.6%-1419.8%-1061.2%-3411.5%   
 
Diluted EPS($1.49)($1.41)($1.56)($1.66)($1.94)($2.16)($1.03)($0.34)
Shares outstanding (diluted)35.631.328.722.020.110.77.45.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy